Rohann Correa

Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial

David A. Palma, Robert Olson, Stephen Harrow et al. · BMC Cancer · 2019 · 268 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK)

Shankar Siva, Alexander V. Louie, Andrew Warner et al. · Cancer · 2017 · 164 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Stereotactic ablative radiotherapy for the comprehensive treatment of 1–3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial

Robert Olson, Lindsay Mathews, Mitchell Liu et al. · BMC Cancer · 2020 · 123 citations · Full text

Medicine, Oncology, Radiation Oncology +12

Modulation of AKT activity is associated with reversible dormancy in ascites-derived epithelial ovarian cancer spheroids

Rohann Correa, Teresa Peart, Yudith Ramos Valdés et al. · Carcinogenesis · 2011 · 100 citations · Full text

Medicine, Cell Biology, Oncology +17

Combination of AKT inhibition with autophagy blockade effectively reduces ascites-derived ovarian cancer cell viability

Rohann Correa, Yudith Ramos Valdés, Teresa Peart et al. · Carcinogenesis · 2014 · 78 citations · Full text

Life Sciences, Oncology, Pharmacology +17